Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Eur J Clin Microbiol Infect Dis ; 42(8): 981-992, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37318601

ABSTRACT

Existing literature about peritoneal tuberculosis (TBP) is relatively insufficient. The majority of reports are from a single center and do not assess predictive factors for mortality. In this international study, we investigated the clinicopathological characteristics of a large series of patients with TBP and determined the key features associated with mortality. TBP patients detected between 2010 and 2022 in 38 medical centers in 13 countries were included in this retrospective cohort. Participating physicians filled out an online questionnaire to report study data. In this study, 208 patients with TBP were included. Mean age of TBP cases was 41.4 ± 17.5 years. One hundred six patients (50.9%) were females. Nineteen patients (9.1%) had HIV infection, 45 (21.6%) had diabetes mellitus, 30 (14.4%) had chronic renal failure, 12 (5.7%) had cirrhosis, 7 (3.3%) had malignancy, and 21 (10.1%) had a history of immunosuppressive medication use. A total of 34 (16.3%) patients died and death was attributable to TBP in all cases. A pioneer mortality predicting model was established and HIV positivity, cirrhosis, abdominal pain, weakness, nausea and vomiting, ascites, isolation of Mycobacterium tuberculosis in peritoneal biopsy samples, TB relapse, advanced age, high serum creatinine and ALT levels, and decreased duration of isoniazid use were significantly related with mortality (p < 0.05). This is the first international study on TBP and is the largest case series to date. We suggest that using the mortality predicting model will allow early identification of high-risk patients likely to die of TBP.


Subject(s)
HIV Infections , Mycobacterium tuberculosis , Tuberculosis , Female , Humans , Young Adult , Adult , Middle Aged , Male , HIV Infections/complications , HIV Infections/drug therapy , Retrospective Studies , Isoniazid , Liver Cirrhosis , Antitubercular Agents/therapeutic use
2.
Ocul Immunol Inflamm ; 31(8): 1677-1686, 2023 Oct.
Article in English | MEDLINE | ID: mdl-36638336

ABSTRACT

AIM: Brucellosis may affect the eye to varying degrees. The aim of this study was to investigate the ocular involvement of brucellosis and highlight key points. MATERIAL AND METHODS: Published literature in English language on the ocular involvement of brucellosis within last 30 years was evaluated. The PubMed international database was screened using certain keywords. RESULTS: The study included 27 publications evaluating a total of 159 cases. The most common types of ocular involvement were uveitis (52.2%) and conjunctivitis (17.6%). Most cases had concomitant systemic brucellosis (27.7%), and the most commonly used diagnostic method was a serological test (92.4%). Of all the patients, 37.1% recovered with sequelae. CONCLUSION: Brucellosis may cause a wide range of ophthalmic manifestations, and an overlooked or late diagnosis may also lead to the development of sequelae or loss of vision. A routine ophthalmologic examination should be performed in all patients with systemic brucellosis.


Subject(s)
Brucellosis , Conjunctivitis , Eye Infections, Bacterial , Uveitis , Humans , Brucellosis/complications , Brucellosis/diagnosis , Brucellosis/epidemiology , Uveitis/diagnosis , Uveitis/epidemiology , Uveitis/etiology , Eye , Conjunctivitis/complications , Eye Infections, Bacterial/diagnosis , Eye Infections, Bacterial/epidemiology , Eye Infections, Bacterial/etiology
3.
J Coll Physicians Surg Pak ; 32(8): 1076-1079, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35932139

ABSTRACT

Brucella infection is often an occupational disease of veterinarians, agricultural workers, and slaughterhouse workers. The infection is generally spread by contact of broken skin (open cuts or wounds) with infected animal tissues or by ingesting unpasteurized milk and dairy products from the infected animals. Brucellosis, which can have many different clinical presentations, may rarely cause joint prosthesis infection. There is not enough literature about the treatment of such infection which should be kept in the differential diagnosis, especially in endemic regions. We aim to present diagnostic and treatment approach of Brucella prosthetic infection in a 70-year woman with total knee arthroplasty. Key Words: Brucella, Prosthesis, Infection, Total knee arthroplasty.


Subject(s)
Arthroplasty, Replacement, Knee , Brucella , Brucellosis , Knee Prosthesis , Occupational Diseases , Animals , Arthroplasty, Replacement, Knee/adverse effects , Brucellosis/diagnosis , Brucellosis/drug therapy , Humans , Knee Prosthesis/adverse effects
4.
J Chemother ; 33(5): 302-318, 2021 Sep.
Article in English | MEDLINE | ID: mdl-33734040

ABSTRACT

We aimed to explore factors for optimizing antimicrobial treatment in emergency departments. A single-day point prevalence survey was conducted on January 18, 2020, in 53 referral/tertiary hospitals in 22 countries. 1957 (17%) of 11557 patients presenting to EDs had infections. The mean qSOFA score was 0.37 ± 0.74. Sepsis (qSOFA ≥ 2) was recorded in 218 (11.1%) patients. The mean qSOFA score was significantly higher in low-middle (1.48 ± 0.963) compared to upper-middle (0.17 ± 0.482) and high-income (0.36 ± 0.714) countries (P < 0.001). Eight (3.7%) patients with sepsis were treated as outpatients. The most common diagnoses were upper-respiratory (n = 877, 43.3%), lower-respiratory (n = 316, 16.1%), and lower-urinary (n = 201, 10.3%) infections. 1085 (55.4%) patients received antibiotics. The most-commonly used antibiotics were beta-lactam (BL) and BL inhibitors (n = 307, 15.7%), third-generation cephalosporins (n = 251, 12.8%), and quinolones (n = 204, 10.5%). Irrational antibiotic use and inappropriate hospitalization decisions seemed possible. Patients were more septic in countries with limited resources. Hence, a better organizational scheme is required.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Communicable Diseases/diagnosis , Communicable Diseases/drug therapy , Drug Utilization/statistics & numerical data , Emergency Service, Hospital/statistics & numerical data , Communicable Diseases/pathology , Developing Countries/statistics & numerical data , Global Health , Humans , Organ Dysfunction Scores , Patient Acuity , Practice Patterns, Physicians' , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/epidemiology , Sepsis/epidemiology , Urologic Neoplasms/drug therapy , Urologic Neoplasms/epidemiology
5.
Eur J Clin Microbiol Infect Dis ; 40(8): 1737-1742, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33586014

ABSTRACT

To describe the change in the epidemiology of health care-associated infections (HAI), resistance and predictors of fatality we conducted a nationwide study in 24 hospitals between 2015 and 2018. The 30-day fatality rate was 22% in 2015 and increased to 25% in 2018. In BSI, a significant increasing trend was observed for Candida and Enterococcus. The highest rate of 30-day fatality was detected among the patients with pneumonia (32%). In pneumonia, Pseudomonas infections increased in 2018. Colistin resistance increased and significantly associated with 30-day fatality in Pseudomonas infections. Among S. aureus methicillin, resistance increased from 31 to 41%.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antifungal Agents/pharmacology , Bacterial Infections/drug therapy , Cross Infection/drug therapy , Cross Infection/microbiology , Mycoses/microbiology , Bacteremia/microbiology , Bacteria/drug effects , Bacterial Infections/microbiology , Candida/drug effects , Drug Resistance, Bacterial , Fungemia/microbiology , Humans , Mycoses/drug therapy , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...